Abstract
Purpose. Sevoflurane, one of the most used general anesthetics, is widely used in clinical practice all over the world. Previous studies indicated that sevoflurane could induce neuron apoptosis and neural deficit causing query in the safety of anesthesia using sevoflurane. The present study was designed to investigate the effects of sevoflurane on electrophysiology in Drosophila pupa whose excitatory neurotransmitter is acetylcholine early after sevoflurane exposure using whole brain recording technique. Methods. Wide types of Drosophila (canton-s flies) were allocated to control and sevoflurane groups randomly. Sevoflurane groups (1% sevoflurane; 2% sevoflurane; 3% sevoflurane) were exposed to sevoflurane and the exposure lasted 5 hours, respectively. All flies were subjected to electrophysiology experiment using patch clamp 24 hours after exposure. Results. The results showed that, 24 hours after sevoflurane exposure, frequency but not the amplitude of miniature excitatory postsynaptic currents (mEPSCs) was significantly reduced (P < 0.05). Furthermore, we explored the underlying mechanism and found that calcium currents density, which partially regulated the frequency of mEPSCs, was significantly reduced after sevoflurane exposure (P < 0.05). Conclusions. All these suggested that sevoflurane could alter the mEPSCs that are related to synaptic plasticity partially through modulating calcium channel early after sevoflurane exposure.
1. Introduction
Sevoflurane, an ether inhalational general anesthetic, with its low pungency, nonirritating odor, and low blood/gas partition coefficient, has been widely used in clinical anesthesia [1]. Additionally, since there is much advancement in surgery recently incidence and duration of exposure to sevoflurane in people receiving surgery are increasing. These raised concerns that whether anesthesia using sevoflurane would contribute to postoperative cognitive dysfunction (POCD) as rodent studies indicated that persistent learning deficit and social behavior dysfunction occurred after general anesthesia [2, 3]. Although recent clinical and laboratory data suggested that exposure to inhalational anesthetics is associated with subsequent learning and memory problems, mechanisms which underline these effects are still not clear. Previous studies indicated that isoflurane, thiopental, propofol, and ketamine would cause neurodegeneration and learning and memory deficiency [4, 5]. These suggested that the neurotoxicity induced by inhalational anesthetic might be mediated by activation of γ-aminobutyric acid (GABA) and inhibition of N-methyl-D-aspartic acid (NMDA) receptor [5–7].
Sevoflurane, like other inhalational anesthetic agents, activates γ-aminobutyric acid (GABA) and blocks N-methyl-D-aspartic acid (NMDA) receptor. Mounting data suggested that sevoflurane could produce histological damage in central nervous system (CNS) and subsequent alterations in behavior [8–10]. Meanwhile sevoflurane at clinical concentration could inhibit neurotransmission in a dose dependent manner in hippocampal slice study [11, 12]. Furthermore, a human volunteers study suggested that 0.25% sevoflurane blocks emotional memory [13]. The effects of sevoflurane on histological change and synaptic transmission of glutamatergic neurons have been well studied; however, there is little known about it on cholinergic neurons after sevoflurane exposure especially cholinergic synaptic transmission.
Cholinergic neurons function has been implicated in learning and memory processes [14]. Impairment of cholinergic system would cause disastrous loss of memory and learning ability [15, 16]. Therefore, it is possible that sevoflurane causes learning and memory impairment through damaging and disturbing cholinergic neurons function. However, cholinergic neurons are minority in mammal brain and it makes investigating cholinergic neurons function after sevoflurane exposure more difficulty.
Drosophila melanogaster has been widely used as model organism to study neuropharmacology, neurodegenerative disease, and neurobiology due to the achievements and advances in the knowledge and methodology in studying Drosophila melanogaster. The projection neurons (PNs) in antennal lobe of Drosophila transferring information from olfactory receptor neurons to mushroom body are known to be cholinergic, and PNs together with other interneurons in antennal lobe establish the complex neurocircuit processing the olfactory information. These provide an ideal model to investigate neurotransmission and neurofunction of cholinergic neurons which are fundamental excitative neurons in CNS of human related to memory [17].
In the present study, we investigated the effects of sevoflurane on neurotransmission and neurofunction after sevoflurane exposure and explored possible underlying mechanisms by using a Drosophila whole brain recording system [18].
2. Materials and Methods
2.1. Flies Stock
Drosophila melanogaster were reared in standard cornmeal agar medium accompanied with dry yeast at 24°C and 60% relative humidity. In order to reduce the errors, all experiments were performed using wild type canton-s flies 2-3 days before eclosion which was selected by red eyes and transparent wing in the puparium.
2.2. Sevoflurane Exposure Protocol
The sevoflurane groups (1% sevoflurane, exposure lasted 5 hours; 2% sevoflurane, exposure lasted 5 hours; 3% sevoflurane, exposure lasted 5 hours) were placed in a special anesthesia glass box, respectively. Gas was delivered through an anesthesia machine. Air was used as carrier and fresh air flow was controlled at 2 L/min. Gas was monitored by a monitor machine (Datex-Ohmeda, Louisville, KY, USA). Temperature in the experiment room was controlled at 24°C and humidity was 60%. 24 hours after sevoflurane exposure, the sevoflurane groups were subjected to experiment.
2.3. Electrophysiological Recording of PNs in Whole Brain Obtained from Drosophila melanogaster
Drosophila whole brains were obtained from control and postanesthesia flies 2-3 days before eclosion. The whole brains were dissected out of the head for experiment in external solution (101 mM NaCl, 1 mM CaCl2, 4 mM MgCl2, 3 mM KCl, 5 mM glucose, 1.25 mM NaH2PO4, 20.7 mM NaHCO3, pH 7.2, and Osm 250 mosM) additionally containing 20 units/mL papain with 1 mM l-cysteine. Pipettes (10–15 MΩ) pulled using a micropipette puller were targeted to PNs in the dorsal neuron cluster at the antennal lobe of brain which were mounted in an RC-26 perfusion chamber (Warner Instruments, Hamden, CT, USA) containing the external solution bubbled with 95% O2 and 5% CO2 (2 mL/min).
Whole-cell recordings were performed with pipettes filled with internal solution (102 mM K-gluconate, 0.085 mM CaCl2, 1.7 mM MgCl2, 17 mM NaCl, 0.94 mM EGTA, 8.5 mM HEPES, pH 7.2, and Osm 235 mosM). The internal solution for calcium current recording was similar except that K-gluconate was replaced by cesium gluconate. Whole-cell configuration was achieved in voltage-clamp mode after Giga ohm seals were completed. Slow and fast capacitance compensation was automatically completed. Access resistance was continuously monitored during the experiments. Current-clamp and voltage-clamp recordings were performed using patch-clamp system.
In order to record cholinergic mEPSCs, TTX (1 μM) and picrotoxin (10 μM) were added to the external solution to block voltage-gated sodium currents and GABAergic synaptic currents, respectively. While recording calcium current, TTX (1 μM), TEA (10 mM), and 4-AP (1 mM) were added. All experiments were performed at room temperature and only one cell was recorded in each brain.
All electrophysiological experiments were performed through a BX51WI upright microscope (Olympus, Lehigh Valley, PA). Data, obtained by EPC10 amplifier (HEKA Elektronik, Lambrecht/Pfalz, Germany), were filtered at 5 kHz using a built-in filter and digitized at 5 kHz. Data analysis was performed by the pClamp10 Clampfit software (Molecular Devices). mEPSCs were analysed by Mini Analysis Software (Synaptosoft, Decatur, GA). Events were accepted for analysis only if they were asymmetrical with a rising phase faster than 3 ms and a more slowly decaying phase. In addition, the threshold criterion for inclusion was 3 pA.
2.4. Biocytin Staining and Immunohistochemistry Images
In order to identify and confirm that the cells recorded were PNs, cells recorded were stained by biocytin. While recording, cells were injected with biocytin through recording pipette filled with internal solution containing biocytin in whole-cell recording mode for at least 30 min. After recording, the brains were collected and fixed in 4% formaldehyde in PBS at 4°C for 10 h. Then brain was rinsed in 1% PBS three times, blocked, and incubated in a blocking buffer (0.1 M PBS, 0.1% Triton X-100, and 1% BSA) containing streptavidin-Cy3 (Molecular Devices) for 3 h at room temperature. After incubation, the brain was washed three times with 5 min intervals in PBS. A BX51WI microscope with a ×40 objective and confocal camera was used to acquire photos of dendritic arborization of the PNs in the antennal lobe.
2.5. Statistic Analysis
Data represented as mean ± S.D. Comparisons between groups were performed by analysis of one way ANOVA followed by Bonferroni-Dunn post hoc test or independent sample t-tests. And P < 0.05 was considered significant.
3. Results
3.1. Confocal Image of PNS of Drosophila Pupa Two Days before Eclosion
In Figure 1, the morphology of PNs was showed in the isolated brain. PNs are members of the synaptic net in which fast excitatory synaptic transmission was mediated by the α-bungarotoxin- (α-BTX-) sensitive nicotinic acetylcholine receptors (nAChRs). Previous studies have indicated that PNs receiving information from antennal lobe project their axon with cholinergic output to Kenyon cells in Drosophila. In the present study, In order to identify and confirm that the cells recorded were PNs all brains recorded were subjected to biocytin staining and immunohistochemistry imaging. Results obtained from cells which were in accordance with the morphology of PNs were accepted to be analyzed.
3.2. Property of Spontaneous Action Potentials (sAP) of Drosophila Pupa Two Days before Eclosion Was Not Altered after Sevoflurane Exposure
In order to study whether sAP which is the fundamental property of neurofunction was changed 24 hours after sevoflurane exposure, we recorded the sAP of PNs from the whole brains isolated from CS pupa 2-3 days before eclosion of control and postanesthesia groups in whole-cell current clamp. While under the whole-cell current- clamp mode, sAP of PNs was recorded. The number of sAP which was over shooting more positive than 0 mV was counted; meanwhile peak amplitude was measured (Figure 2(a) n = 6, N = 24). Neither frequency nor amplitude was altered 24 hours after sevoflurane exposure when compared to control group (P > 0.05) (Figures 2(b) and 2(c)).
3.3. Cholinergic Miniature Excitatory Postsynaptic Currents (mEPSCs) of Drosophila Pupa Two Days before Eclosion Were Altered after Sevoflurane Exposure
mEPSCs recorded from PNs have been proved to be mediated by acetylcholine by adding curare a nicotinic neuromuscular acetylcholine receptors antagonist. In the present study, mEPSCs were recorded from PNs in the presence of TTX and PTX in control and sevoflurane groups 24 hours after sevoflurane exposure. In control group, mean frequency and amplitude of mEPSCs were 1.60 ± 0.0875 and 6.80 ± 0.614 pA, respectively. In sevoflurane groups (1%, exposure lasted 5 hours; 2%, exposure lasted 5 hours; 3% exposure lasted 5 hours), mean frequency of mEPSCs was significantly reduced to 0.510 ± 0.140, 0.438 ± 0.134, and 0.329 ± 0.0765, respectively, when compared to control group (P < 0.05, n = 6, N = 24, Figure 3(b)) and it showed slight dose dependent effects (Figure 3(b)). However, amplitude of mEPSCs was not changed after sevoflurane exposure (P > 0.05, n = 6, N = 24, Figure 3(c)).
3.4. Calcium Currents of Drosophila Pupa Two Days before Eclosion Were Altered after Sevoflurane Exposure
In order to explorer the underlying mechanisms, we investigated whether sevoflurane would alter the calcium currents. In the experiment of recording calcium currents, internal solution which was the same as those used in recording mEPSCs except that potassium gluconate was replaced by cesium gluconate was used to record in the presence of TTX (1 μM), TEA (10 mM), and 4-AP (1 mM). In order to reduce errors due to the size of the cells, data were showed in the form of current density. Data showed that mean peak amplitude in control group was 6.06 ± 1.65 pA/pF. And in sevoflurane groups (1%, exposure lasted 5 hours; 2%, exposure lasted 5 hours; 3% exposure lasted 5 hours), mean peak amplitude was significantly reduced to 4.32 ± 1.48 pA/pF, 2.65 ± 0.738 pA/pF, and 2.69 ± 2.40 pA/pF, respectively, when compared to control group (Figure 4).
4. Discussion
Presently, using Drosophila whose majority neurons are cholinergic whole brain recording system [18, 19], we are able to record cholinergic synaptic transmission in an intact nuerocircuit after anesthesia, which is hard to achieve in mammal animals.
In our study, all recorded neurons were showed in the brain through method of biocytin staining and immunohistochemistry. In order to reduce the error in experiments and make the data more reliable, data recorded from neurons in Drosophila brain whose location and morphology are in accordance with the PNs were accepted to further analysis (Figure 1).
In the present study, neither the frequency nor the amplitude of sAP were altered 24 hours after exposing Drosophila pupa to three concentrations of sevoflurane. It is well known that action potential is a fundamental property of neurons in mammal brain. It reflects ions that exchange across cell membrane through ion channel especially voltage-gate sodium channel. Previous studies suggested that sevoflurane while in clinical concentration inhibits sodium channel hence blocking action potential which is thought to lead to anesthesia effects [20]. All these indicated that fundamental property of neurons was not altered after sevoflurane exposure.
The mEPSCs are believed to result from spontaneous fusion of vesicles containing neurotransmitter to presynaptic terminal membrane. Frequency and amplitude of mEPSCs reflect the synaptic transmission activity. Alterations of frequency and amplitude of mEPSCs are ascribed to presynaptic and postsynaptic action, respectively [21]. Amplitude of mEPSCs reflects the response of postsynaptic receptor to a single vesicle while frequency reflects the possibility of vesicle fusion and release [22]. Previous studies indicated that the strength of synaptic transmission reflecting synaptic plasticity is dramatically modified by prior synaptic transmission activity, which can be expressed as metaplasticity. Studies from Sastry and Bhagavatula suggested that LTP is associated with an increase in frequency of mEPSCs [23]. Kushner et al. found that increasing phosphorylation of synapsin I in mice could enhance the density of docked vesicle in presynaptic membrane increasing the frequency of mEPSCs [24]. These changes facilitated subsequent induction of LTP and these mice showed an enhancement in learning and memory. Yang also found that melamine could reduce the frequency of mEPSCs hence diminishing the LTP and then impair the learning and memory of rats. It suggested that reducing synaptic transmission activity as shown in decreasing the frequency of mEPSCs could impair LTP [22, 25]. In order to determine whether synaptic transmission activity was modified, we measured the mEPSCs and found that the frequency of it was significantly reduced to 0.510 ± 0.140, 0.438 ± 0.134, and 0.329 ± 0.0765 24 h after sevoflurane exposure in sevoflurane groups, respectively, when compared to control group (1.6 ± 0.0875) while amplitude was not changed. Theses suggested that cholinergic synaptic transmission activity was inhibited 24 hours after sevoflurane exposure causing alteration of synaptic plasticity and subsequent learning and memory deficit through presynaptic mechanisms.
There are many factors that could contribute to modification of presynaptic transmitters release altering the frequency of mEPSCs. Studies showed that frequency of mEPSCs is associated with calcium. Lee et al. found that frequency of mEPSCs in cholinergic neurons was partially regulated by calcium currents [26]. Data showed that reducing influx of calcium through voltage-gate calcium channels decreased the frequency of mEPSCs, probability of neurotransmitter release from presynaptic membrane, by adding Co2+ which blocked calcium channels [27]. In order to explore the underlined mechanism that sevoflurane decreases the frequency of mEPSCs, calcium currents were measured 24 hours after sevoflurane exposure. And data showed that mean peak calcium currents density in sevoflurane groups was significantly reduced to 4.32 ± 1.48 pA/pF, 2.65 ± 0.738 pA/pF, and 2.69 ± 2.40 pA/p, respectively, 24 hours after sevoflurane exposure when compared to control group. It showed a slight dose dependent inhibition which was similar to that on the frequency of mEPSCs. This indicated that mean calcium currents were inhibited 24 hours after sevoflurane hence reducing the frequency of mEPSCs, which impaired the synaptic plasticity and subsequent learning and memory function. However, whether these effects would last for a life time and the detail mechanisms are not well understood and it needs to be elucidated in our further investigation.
5. Conclusion
In the present study, we found that, 24 hours after sevoflurane exposure, frequency of mEPSC and peak amplitude of calcium current density were reduced in slight dose dependent effects while amplitude of mEPSCs, frequency, and amplitude of sAP were not altered using Drosophila melanogaster whole brain recording model. These data indicated that sevoflurane may alter central nervous system synaptic plasticity partially through inhibiting calcium current 24 hours after sevoflurane exposure which decreased the presynaptic neurotransmitter release.
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this paper.
Authors' Contribution
Rongfa Chen and Tao Zhang contributed equally to this work.
References
- 1.Zhang X., Xue Z., Sun A. Subclinical concentration of sevoflurane potentiates neuronal apoptosis in the developing C57BL/6 mouse brain. Neuroscience Letters. 2008;447(2-3):109–114. doi: 10.1016/j.neulet.2008.09.083. [DOI] [PubMed] [Google Scholar]
- 2.Culley D. J., Baxter M. G., Yukhananov R., Crosby G. Long-term impairment of acquisition of a spatial memory task following isoflurane -nitrous oxide anesthesia in rats. Anesthesiology. 2004;100(2):309–314. doi: 10.1097/00000542-200402000-00020. [DOI] [PubMed] [Google Scholar]
- 3.Satomoto M. Neonatal exposure to sevoflurane induces abnormal social behaviors and deficits in fear conditioning in mice. Masui. 2010;59:S196–S205. [PubMed] [Google Scholar]
- 4.Jevtovic-Todorovic V., Hartman R. E., Izumi Y., et al. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. The Journal of Neuroscience. 2003;23(3):876–882. doi: 10.1523/JNEUROSCI.23-03-00876.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Fredriksson A., Pontén E., Gordh T., Eriksson P. Neonatal exposure to a combination of N-Methyl-D-aspartate and γ-aminobutyric acid type A receptor anesthetic agents potentiates apoptotic neurodegeneration and persistent behavioral deficits. Anesthesiology. 2007;107(3):427–436. doi: 10.1097/01.anes.0000278892.62305.9c. [DOI] [PubMed] [Google Scholar]
- 6.Shu Y., Zhou Z., Wan Y., et al. Nociceptive stimuli enhance anesthetic-induced neuroapoptosis in the rat developing brain. Neurobiology of Disease. 2012;45(2):743–750. doi: 10.1016/j.nbd.2011.10.021. [DOI] [PubMed] [Google Scholar]
- 7.Istaphanous G. K., Howard J., Nan X., et al. Comparison of the neuroapoptotic properties of equipotent anesthetic concentrations of desflurane, isoflurane, or sevoflurane in neonatal mice. Anesthesiology. 2011;114(3):578–587. doi: 10.1097/ALN.0b013e3182084a70. [DOI] [PubMed] [Google Scholar]
- 8.Bercker S., Bert B., Bittigau P., et al. Neurodegeneration in newborn rats following propofol and sevoflurane anesthesia. Neurotoxicity Research. 2009;16(2):140–147. doi: 10.1007/s12640-009-9063-8. [DOI] [PubMed] [Google Scholar]
- 9.Liang G., Ward C., Peng J., Zhao Y., Huang B., Wei H. Isoflurane causes greater neurodegeneration than an equivalent exposure of sevoflurane in the developing brain of neonatal mice. Anesthesiology. 2010;112(6):1325–1334. doi: 10.1097/ALN.0b013e3181d94da5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Kostopanagiotou G., Kalimeris K., Kesidis K., et al. Sevoflurane impairs post-operative olfactory memory but preserves olfactory function. European Journal of Anaesthesiology. 2011;28(1):63–68. doi: 10.1097/EJA.0b013e328340702b. [DOI] [PubMed] [Google Scholar]
- 11.Ishizeki J., Nishikawa K., Kubo K., Saito S., Goto F. Amnestic concentrations of sevoflurane inhibit synaptic plasticity of hippocampal CA1 neurons through γ-aminobutyric acid-mediated mechanisms. Anesthesiology. 2008;108(3):447–456. doi: 10.1097/ALN.0b013e318164cfba. [DOI] [PubMed] [Google Scholar]
- 12.Haseneder R., Kratzer S., von Meyer L., Eder M., Kochs E., Rammes G. Isoflurane and sevoflurane dose-dependently impair hippocampal long-term potentiation. European Journal of Pharmacology. 2009;623(1–3):47–51. doi: 10.1016/j.ejphar.2009.09.022. [DOI] [PubMed] [Google Scholar]
- 13.Alkire M. T., Gruver R., Miller J., McReynolds J. R., Hahn E. L., Cahill L. Neuroimaging analysis of an anesthetic gas that blocks human emotional memory. Proceedings of the National Academy of Sciences of the United States of America. 2008;105(5):1722–1727. doi: 10.1073/pnas.0711651105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Lima A. P. A. S., Silva K., Padovan C. M., Almeida S. S., Fukuda M. T. H. Memory, learning, and participation of the cholinergic system in young rats exposed to environmental enrichment. Behavioural Brain Research. 2014;259:247–252. doi: 10.1016/j.bbr.2013.10.046. [DOI] [PubMed] [Google Scholar]
- 15.Stepanichev M., Lazareva N., Tukhbatova G., Salozhin S., Gulyaeva N. Transient disturbances in contextual fear memory induced by Aβ(25–35) in rats are accompanied by cholinergic dysfunction. Behavioural Brain Research. 2014;259:152–157. doi: 10.1016/j.bbr.2013.11.013. [DOI] [PubMed] [Google Scholar]
- 16.Lee Y.-S., Danandeh A., Baratta J., Lin C.-Y., Yu J., Robertson R. T. Neurotrophic factors rescue basal forebrain cholinergic neurons and improve performance on a spatial learning test. Experimental Neurology. 2013;249:178–186. doi: 10.1016/j.expneurol.2013.08.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Ng M., Roorda R. D., Lima S. Q., Zemelman B. V., Morcillo P., Miesenböck G. Transmission of olfactory information between three populations of neurons in the antennal lobe of the fly. Neuron. 2002;36(3):463–474. doi: 10.1016/S0896-6273(02)00975-3. [DOI] [PubMed] [Google Scholar]
- 18.Gu H., O'Dowd D. K. Whole cell recordings from brain of adult drosophila. Journal of Visualized Experiments. 2007;(6, article e248) doi: 10.3791/248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Gu H., O'Dowd D. K. Cholinergic synaptic transmission in adult Drosophila Kenyon cells in situ. Journal of Neuroscience. 2006;26(1):265–272. doi: 10.1523/JNEUROSCI.4109-05.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Yokoyama T., Minami K., Sudo Y., et al. Effects of sevoflurane on voltage-gated sodium channel Nav1.8, Nav1.7, and Nav1.4 expressed in Xenopus oocytes . Journal of Anesthesia. 2011;25(4):609–613. doi: 10.1007/s00540-011-1167-7. [DOI] [PubMed] [Google Scholar]
- 21.Simkus C. R. L., Stricker C. The contribution of intracellular calcium stores to mEPSCs recorded in layer II neurones of rat barrel cortex. Journal of Physiology. 2002;545(2):521–535. doi: 10.1113/jphysiol.2002.022103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Yang J., An L., Yao Y., Yang Z., Zhang T. Melamine impairs spatial cognition and hippocampal synaptic plasticity by presynaptic inhibition of glutamatergic transmission in infant rats. Toxicology. 2011;289(2-3):167–174. doi: 10.1016/j.tox.2011.08.011. [DOI] [PubMed] [Google Scholar]
- 23.Sastry B. R., Bhagavatula L. S. Quantal release of transmitter at a central synapse. Neuroscience. 1996;75(4):987–992. doi: 10.1016/0306-4522(96)00348-X. [DOI] [PubMed] [Google Scholar]
- 24.Kushner S. A., Elgersma Y., Murphy G. G., et al. Modulation of presynaptic plasticity and learning by the H-ras/extracellular signal-regulated kinase/synapsin I signaling pathway. Journal of Neuroscience. 2005;25(42):9721–9734. doi: 10.1523/JNEUROSCI.2836-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Yang Y., Xiong G. J., Yu D. F., et al. Acute low-dose melamine affects hippocampal synaptic plasticity and behavior in rats. Toxicology Letters. 2012;214(1):63–68. doi: 10.1016/j.toxlet.2012.08.010. [DOI] [PubMed] [Google Scholar]
- 26.Lee D., Su H., O'Dowd D. K. GABA receptors containing Rdl subunits mediate fast inhibitory synaptic transmission in Drosophila neurons. The Journal of Neuroscience. 2003;23(11):4625–4634. doi: 10.1523/JNEUROSCI.23-11-04625.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Amaral M. D., Pozzo-Miller L. Intracellular Ca2+ stores and Ca2+ influx are both required for BDNF to rapidly increase quantal vesicular transmitter release. Neural Plasticity. 2012;2012:10. doi: 10.1155/2012/203536.203536 [DOI] [PMC free article] [PubMed] [Google Scholar]